Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
Holders of 5% or more of VYNT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vyant Bio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Vyant Bio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Vyant Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | FOD Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | FOD Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Lind Global Macro Fund LP | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2022 | Bigger Capital Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 25, 2021 | FiveT Investment Management Ltd | 13DOld format | – | New | – | SEC |
| Feb 11, 2021 | Ionic Ventures, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Intracoastal Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | Bigger Capital Fund L P | 13GOld format | – | New | – | SEC |
| Feb 3, 2021 | Lind Global Macro Fund LP | 13GOld format | – | New | – | SEC |
| Jan 14, 2021 | Alpha Capital Anstalt | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vyant Bio, Inc. shares.
No Form 144 notices for Vyant Bio, Inc. are on file.